Civic AI
Procurement intelligence
Federal contract award
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
LEIDOS BIOMEDICAL RESEARCH INC · Department of Health and Human Services
- Value
- $24,095,572
- Start
- Sep 23, 2019
- End
- Sep 18, 2029
- Action date
- May 19, 2026
- PIID
- 75N91019F00138
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- FREDERICK, MD
- Award type
- DELIVERY ORDER
Description
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS
Need modifications, related awards, and vendor peers? Open the full award workspace.